Overview |
bs-2526R |
CD160/By55 Polyclonal Antibody |
WB, ELISA, FCM, IHC-P, IF(IHC-P) |
Human, Rat |
Mouse, Dog |
Specifications |
Unconjugated |
Rabbit |
KLH conjugated synthetic peptide derived from human CD160 |
81-159/181 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target |
11126 |
O95971 |
Cell membrane |
NK1; BY55; NK28; CD160 antigen; Natural killer cell receptor BY55; CD160 |
CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine rich, glycosylphosphatidylinositol anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. |
Application Dilution |
WB |
1:300-5000 |
ELISA |
1:500-1000 |
FCM |
1:20-100 |
IHC-P |
1:200-400 |
IF(IHC-P) |
1:50-200 |